Innovation And Access: Fission Or Fusion? Interview With Tim Wilsdon, CRA Vice President 25/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Tim Wilsdon, Vice President, CRA.
Unaffordable Medicines Now Global Issue; System Needs Change, Panellists Say 25/05/2016 by Catherine Saez, Intellectual Property Watch 5 Comments At a side event to this week’s annual World Health Assembly, a member of the Netherlands Ministry of Health delivered an unexpected speech on access to medicines, calling for more clarity in the setting of medicine prices, looking inside and outside of the patent system for solutions, and praising de-linkage. Other panellists viewed partnerships as a key ingredient to fill research and development gaps. And a representative from the Gates Foundation advised against a hasty switch to new system.
Countries ‘Disappointed’ With WHO Reform Progress 25/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment The World Health Organization secretariat this week reported to its member states on progress made in implementing sweeping programmatic, governance, and management reforms. The report? WHO has made progress, but there is still a long way to go. Member states, meanwhile, used the opportunity to express concern about the way it is going.
WHO Engagement With Outside Actors: Delegates Tight-Lipped, Civil Society Worried 24/05/2016 by Catherine Saez, Intellectual Property Watch 2 Comments This week, country delegates meeting at the annual World Health Assembly are expected to come to an agreement on a framework managing the UN World Health Organization’s relationship with outside actors, such as the private sector, philanthropic organisations and civil society groups.
Transition Of Core Internet Functions (IANA) Oversight From US Government No Done Deal 24/05/2016 by Monika Ermert for Intellectual Property Watch 1 Comment Will the US National Telecommunications and Information Administration (NTIA) be able to handover oversight over the management of the DNS root zone and other core databases of the internet in September? At a hearing of the Senate Commerce Committee in Washington today, proponents and opponents showed off and Senator Marco Rubio, former presidential candidate, strongly […]
Initiative To Find New Antibiotics Launched At WHA 24/05/2016 by Intellectual Property Watch 3 Comments A new initiative seeking to develop new antibiotic treatments is being launched today at the annual World Health Assembly. The Global Antibiotic Research and Development (GARD) is a partnership between the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi).
Global Health R&D Under Debate At World Health Assembly 24/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment What’s at stake for global health R&D during WHA 69? This was the question of the moment at a World Health Assembly side event panel yesterday. Image Credits: Mara Pillinger
US High Court To Consider IP Protection For Clothing Design 24/05/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Fashion in the US generates over $330 billion in annual revenues, but it is more than a business. Fashion is a well-recognized art, displayed in numerous museum exhibitions throughout the world. This art, however, receives little IP protection in the US. But a case before the US Supreme Court could change that.
Health Systems, Collaboration, Research Funding Before Innovation, Speakers Say 23/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The fight against epidemics cannot only rely on innovation, according to speakers at an event organised by the pharmaceutical industry alongside the annual World Health Assembly’s opening day. Strong health systems, collaboration of all stakeholders, preventive measures, and the ability to fund research are prerequisite to innovation, they said.
WHO Director Advocates Strong Health Systems, Warns Against Profit-Oriented Mechanisms 23/05/2016 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Assembly opened today with World Health Organization Director General Margaret Chan repeating that this year has a record number of agenda items and over 3,000 participants. She slapped at profit-seeking mechanisms leading to “slow-motion disasters,” which put economic interests above concerns about well-being. In particular, she underlined the lack of research and development for antimicrobial treatments and the rise of chronic non-communicable diseases.